1278107

Molecular PharmaGroup LLC — FEI 3014413265

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 11, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Providence, NJ (United States)

Citations

IDCFRDescription
143621 CFR 211.42(c)(10)(vi)Equipment to control conditions
145121 CFR 211.113(b)Procedures for sterile drug products
194321 CFR 211.180(e)(1)Review of representative number of batches